Should I buy or sell GoHealth stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GOCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GOCO, but not buy additional shares or sell existing shares. View GOCO analyst ratings or view top-rated stocks .

What is GoHealth's stock price target for 2024?

1 brokers have issued 12 month price targets for GoHealth's stock. Their GOCO share price targets range from $13.00 to $13.00. On average, they predict the company's stock price to reach $13.00 in the next year. This suggests a possible upside of 31.2% from the stock's current price. View analysts price targets for GOCO or view top-rated stocks among Wall Street analysts .

How have GOCO shares performed in 2024?

GoHealth's stock was trading at $13.34 on January 1st, 2024. Since then, GOCO stock has decreased by 25.7% and is now trading at $9.91. View the best growth stocks for 2024 here .

Are investors shorting GoHealth?

GoHealth saw a increase in short interest in March. As of March 31st, there was short interest totaling 223,400 shares, an increase of 8.9% from the March 15th total of 205,100 shares. Based on an average daily trading volume, of 15,000 shares, the short-interest ratio is currently 14.9 days. Currently, 3.0% of the shares of the stock are sold short. View GoHealth's Short Interest .

When is GoHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our GOCO earnings forecast .

How were GoHealth's earnings last quarter?

GoHealth, Inc. (NASDAQ:GOCO) posted its earnings results on Thursday, March, 14th. The company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.73 by $2.13. The company had revenue of $276.70 million for the quarter, compared to the consensus estimate of $362.38 million. GoHealth had a negative net margin of 8.61% and a negative trailing twelve-month return on equity of 9.29%.

What is Matthew Crummack's approval rating as GoHealth's CEO?

25 employees have rated GoHealth Chief Executive Officer Matthew Crummack on Glassdoor.com . Matthew Crummack has an approval rating of 90% among the company's employees.

What other stocks do shareholders of GoHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GoHealth investors own include Tesla (TSLA) , Alibaba Group (BABA) , CVS Health (CVS) , Moderna (MRNA) , RTX (RTX) , Walmart (WMT) , Cisco Systems (CSCO) , Intel (INTC) and Johnson & Johnson (JNJ) .

When did GoHealth IPO?

GoHealth (GOCO) raised $750 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 39,500,000 shares at a price of $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley served as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

How do I buy shares of GoHealth?

Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:GOCO

GoHealth (GOCO) Stock Price, News & Analysis

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Free GOCO Stock Alerts

$9.91

-0.11 (-1.10%)

(As of 04/17/2024 ET)

Compare

Today's Range: $9.69
▼
$10.19
50-Day Range: $9.53
▼
$14.07
52-Week Range: $7.05
▼
$22.85

Volume: 18,376 shs
Average Volume: 15,251 shs
Market Capitalization: $222.78 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.00

Get GoHealth alerts:

GoHealth MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 31.2% Upside
$13.00 Price Target
Short Interest: Bearish
2.95% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.23
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($5.22) to ($4.33) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.24 out of 5 stars

Finance Sector

733rd out of 828 stocks

Insurance Agents, Brokers, & Service Industry

16th out of 17 stocks

3.0

Analyst's Opinion

Consensus Rating
GoHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
GoHealth has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
2.95% of the float of GoHealth has been sold short.
Short Interest Ratio / Days to Cover
GoHealth has a short interest ratio ("days to cover") of 14.9, which indicates bearish sentiment.
Change versus previous month
Short interest in GoHealth has recently increased by 8.92%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
GoHealth does not currently pay a dividend.
Dividend Growth
GoHealth does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for GOCO.

1.8

News and Social Media Coverage

News Sentiment
GoHealth has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Finance companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for GoHealth this week, compared to 1 article on an average week.
MarketBeat Follows
Only 1 people have added GoHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, GoHealth insiders have not sold or bought any company stock.
Percentage Held by Insiders
52.00% of the stock of GoHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 24.21% of the stock of GoHealth is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for GoHealth are expected to grow in the coming year, from ($5.22) to ($4.33) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of GoHealth is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of GoHealth is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
GoHealth has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About GoHealth Stock (NASDAQ:GOCO)

GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.

GOCO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GOCO Stock News Headlines

April 16, 2024 | finance.yahoo.com

GoHealth, Inc. (GOCO)

April 2, 2024 | msn.com

Upcoming Deadline to Share in GoHealth, Inc. (GOCO) Class Action Settlement

April 17, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 28, 2024 | finance.yahoo.com

GoHealth to Present at Medicarians 2024: The Home of Senior Health, Wealth, and AgeTech

March 26, 2024 | globenewswire.com

GoHealth to Present at the LD Micro Invitational XIV

March 16, 2024 | seekingalpha.com

GoHealth, Inc. (GOCO) Q4 2023 Earnings Call Transcript

March 16, 2024 | finance.yahoo.com

GoHealth, Inc. (NASDAQ:GOCO) Q4 2023 Earnings Call Transcript

March 14, 2024 | pymnts.com

GoHealth's Data Science Platform Draws 75% of Enrollments

April 17, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 14, 2024 | finanznachrichten.de

GoHealth, Inc.: GoHealth Reports Fourth Quarter and Fiscal 2023 Results

March 14, 2024 | finance.yahoo.com

GoHealth Inc (GOCO) Reports Significant Cash Flow Improvement and Revenue Growth in Fiscal 2023

March 14, 2024 | globenewswire.com

GoHealth Reports Fourth Quarter and Fiscal 2023 Results

March 14, 2024 | benzinga.com

Earnings Outlook For GoHealth

March 13, 2024 | markets.businessinsider.com

GoHealth A earnings: here's what Wall Street expects

February 22, 2024 | finance.yahoo.com

GoHealth to Announce Fourth Quarter and Year End 2023 Results on March 14, 2024

February 22, 2024 | globenewswire.com

GoHealth to Announce Fourth Quarter and Year End 2023 Results on March 14, 2024

February 3, 2024 | bizjournals.com

See GoHealth's upgraded Chicago office at the Merchandise Mart (PHOTOS)

January 5, 2024 | ca.finance.yahoo.com

GoHealth, Inc. (GOCO) Stock Historical Prices & Data - Yahoo Finance

December 27, 2023 | finance.yahoo.com

GoHealth (GOCO) Is Attractively Priced Despite Fast-paced Momentum

December 21, 2023 | finance.yahoo.com

Is GoHealth (GOCO) a Great Value Stock Right Now?

December 14, 2023 | barrons.com

GoHealth Inc.

November 30, 2023 | msn.com

Should Value Investors Buy GoHealth (GOCO) Stock?

November 16, 2023 | finance.yahoo.com

Insider Buying: CEO Vijay Kotte Acquires 7,500 Shares of GoHealth Inc (GOCO)

November 14, 2023 | msn.com

GoHealth (GOCO) Upgraded to Buy: Here's What You Should Know

November 10, 2023 | finance.yahoo.com

GoHealth, Inc. (NASDAQ:GOCO) Q3 2023 Earnings Call Transcript

November 9, 2023 | finance.yahoo.com

GoHealth to Participate in November Conferences

November 9, 2023 | msn.com

GoHealth GAAP EPS of -$2.61 beats by $0.29, revenue of $132M misses by $6.25M

See More Headlines

Receive GOCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/14/2024
Today: 4/17/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Finance
Industry: Insurance agents, brokers, & service
Sub-Industry: N/A
Current Symbol: NASDAQ:GOCO
CUSIP: N/A
CIK: 1808220
Web: www.gohealth.com
Phone: 312-386-8200
Fax: N/A
Employees: 2,530
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $13.00
High Stock Price Target: $13.00
Low Stock Price Target: $13.00
Potential Upside/Downside: +32.1%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($7.22)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-63,260,000.00
Net Margins: -8.61%
Pretax Margin: -20.57%
Return on Equity: -9.29%
Return on Assets: -2.79%

Debt

Debt-to-Equity Ratio: 1.54
Current Ratio: 1.29
Quick Ratio: 1.29

Sales & Book Value

Annual Sales: $734.67 million
Price / Sales: 0.30
Cash Flow: $2.90 per share
Price / Cash Flow: 3.39
Book Value: $18.06 per share
Price / Book: 0.54

Miscellaneous

Outstanding Shares: 22,480,000
Free Float: 10,791,000
Market Cap: $221.20 million
Optionable: Not Optionable
Beta: 1.79

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Brandon M. Cruz (Age 46)
Co-Founder & Non-Executive Co-Chairman
Comp: $159.62k
Mr. Clinton P. Jones (Age 46)
Co-Founder & Non-Executive Co-Chairman
Comp: $1.16M
Mr. Vijay Kumar Kotte (Age 45)
CEO & Director
Comp: $2.54M
Mr. Jason Schulz (Age 46)
Chief Financial Officer
Comp: $1.22M
Mr. Michael Hargis (Age 52)
Chief Operating Officer
Mr. Jay Sreedharan
Chief Technology Officer
Mr. John E. Shave III
Vice President of Investor Relations
Mr. Bradley Burd Esq. (Age 46)
Chief Legal Officer & Corporate Secretary
Mr. Stephen Moffat
Chief Marketing Officer
Ms. Alison Moriarty
Chief People Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

GOCO Stock Analysis - Frequently Asked Questions

Should I buy or sell GoHealth stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GOCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GOCO, but not buy additional shares or sell existing shares.
View GOCO analyst ratings or view top-rated stocks.
What is GoHealth's stock price target for 2024?: 1 brokers have issued 12 month price targets for GoHealth's stock. Their GOCO share price targets range from $13.00 to $13.00. On average, they predict the company's stock price to reach $13.00 in the next year. This suggests a possible upside of 31.2% from the stock's current price.
View analysts price targets for GOCO or view top-rated stocks among Wall Street analysts.
How have GOCO shares performed in 2024?: GoHealth's stock was trading at $13.34 on January 1st, 2024. Since then, GOCO stock has decreased by 25.7% and is now trading at $9.91.
View the best growth stocks for 2024 here.
Are investors shorting GoHealth?: GoHealth saw a increase in short interest in March. As of March 31st, there was short interest totaling 223,400 shares, an increase of 8.9% from the March 15th total of 205,100 shares. Based on an average daily trading volume, of 15,000 shares, the short-interest ratio is currently 14.9 days. Currently, 3.0% of the shares of the stock are sold short.
View GoHealth's Short Interest.
When is GoHealth's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our GOCO earnings forecast.
How were GoHealth's earnings last quarter?: GoHealth, Inc. (NASDAQ:GOCO) posted its earnings results on Thursday, March, 14th. The company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.73 by $2.13. The company had revenue of $276.70 million for the quarter, compared to the consensus estimate of $362.38 million. GoHealth had a negative net margin of 8.61% and a negative trailing twelve-month return on equity of 9.29%.

What is Matthew Crummack's approval rating as GoHealth's CEO?: 25 employees have rated GoHealth Chief Executive Officer Matthew Crummack on Glassdoor.com. Matthew Crummack has an approval rating of 90% among the company's employees.
What other stocks do shareholders of GoHealth own?: Based on aggregate information from My MarketBeat watchlists, some companies that other GoHealth investors own include Tesla (TSLA), Alibaba Group (BABA), CVS Health (CVS), Moderna (MRNA), RTX (RTX), Walmart (WMT), Cisco Systems (CSCO), Intel (INTC) and Johnson & Johnson (JNJ).
When did GoHealth IPO?: GoHealth (GOCO) raised $750 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 39,500,000 shares at a price of $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley served as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.
How do I buy shares of GoHealth?: Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GOCO) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial